Association study between polymorphisms in glutathione-related genes and methamphetamine use disorder in a Japanese population

Tasuku Hashimoto, Kenji Hashimoto, Ryosuke Miyatake, Daisuke Matsuzawa, Yoshimoto Sekine, Toshiya Inada, Norio Ozaki, Nakao Iwata, Mutsuo Harano, Tokutaro Komiyama, Mitsuhiko Yamada, Ichiro Sora, Hiroshi Ujike, Masaomi Iyo

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

Accumulating evidence suggests that oxidative stress plays a role in the mechanisms of action of methamphetamine (METH) in the brain. In the present study, we investigated the association between the genetic polymorphisms among glutathione (GSH)-related enzymes; glutathione S-transferases (GSTs) such as GSTT1 (Non-deletion/Null), GSTT2 (Met139Ile), GSTA1 (-69C/T), and GSTO1 (Ala140Asp); glutathione peroxidase 1 (GPX1) (Pro198Leu); and glutamate-cysteine ligase modifier (GCLM) subunit and METH use disorder in a Japanese population. Two hundred eighteen METH abusers and 233 healthy controls were enrolled in the study. There was a significant difference in GSTT1 genotype frequency between patients with METH psychosis and controls (P = 0.039, odds ratio: 1.52, 95% CI 1.03-2.24). Furthermore, the frequency (66.0%) of the GSTT1 null genotype among prolonged-type METH psychotic patients with spontaneous relapse was significantly higher (P = 0.025, odds ratio: 2.43, 95% CI 1.13-5.23) than that (44.4%) of transient-type METH psychotic patients without spontaneous relapse. However, there were no associations between the polymorphisms of other genes and METH abuse. The present study suggests that the polymorphism of the GSTT1 gene might be a genetic risk factor of the development of METH psychosis in a Japanese population.

Original languageEnglish
Pages (from-to)1040-1046
Number of pages7
JournalAmerican Journal of Medical Genetics, Part B: Neuropsychiatric Genetics
Volume147
Issue number7
DOIs
Publication statusPublished - 05-10-2008

Fingerprint

Methamphetamine
Glutathione
Population
Genes
Psychotic Disorders
Odds Ratio
Genotype
Glutamate-Cysteine Ligase
Recurrence
Genetic Polymorphisms
Glutathione Transferase
Oxidative Stress
Brain
Enzymes

All Science Journal Classification (ASJC) codes

  • Genetics(clinical)
  • Psychiatry and Mental health
  • Cellular and Molecular Neuroscience

Cite this

Hashimoto, Tasuku ; Hashimoto, Kenji ; Miyatake, Ryosuke ; Matsuzawa, Daisuke ; Sekine, Yoshimoto ; Inada, Toshiya ; Ozaki, Norio ; Iwata, Nakao ; Harano, Mutsuo ; Komiyama, Tokutaro ; Yamada, Mitsuhiko ; Sora, Ichiro ; Ujike, Hiroshi ; Iyo, Masaomi. / Association study between polymorphisms in glutathione-related genes and methamphetamine use disorder in a Japanese population. In: American Journal of Medical Genetics, Part B: Neuropsychiatric Genetics. 2008 ; Vol. 147, No. 7. pp. 1040-1046.
@article{732a46c9da0a4d25b840c79de0a4bbaf,
title = "Association study between polymorphisms in glutathione-related genes and methamphetamine use disorder in a Japanese population",
abstract = "Accumulating evidence suggests that oxidative stress plays a role in the mechanisms of action of methamphetamine (METH) in the brain. In the present study, we investigated the association between the genetic polymorphisms among glutathione (GSH)-related enzymes; glutathione S-transferases (GSTs) such as GSTT1 (Non-deletion/Null), GSTT2 (Met139Ile), GSTA1 (-69C/T), and GSTO1 (Ala140Asp); glutathione peroxidase 1 (GPX1) (Pro198Leu); and glutamate-cysteine ligase modifier (GCLM) subunit and METH use disorder in a Japanese population. Two hundred eighteen METH abusers and 233 healthy controls were enrolled in the study. There was a significant difference in GSTT1 genotype frequency between patients with METH psychosis and controls (P = 0.039, odds ratio: 1.52, 95{\%} CI 1.03-2.24). Furthermore, the frequency (66.0{\%}) of the GSTT1 null genotype among prolonged-type METH psychotic patients with spontaneous relapse was significantly higher (P = 0.025, odds ratio: 2.43, 95{\%} CI 1.13-5.23) than that (44.4{\%}) of transient-type METH psychotic patients without spontaneous relapse. However, there were no associations between the polymorphisms of other genes and METH abuse. The present study suggests that the polymorphism of the GSTT1 gene might be a genetic risk factor of the development of METH psychosis in a Japanese population.",
author = "Tasuku Hashimoto and Kenji Hashimoto and Ryosuke Miyatake and Daisuke Matsuzawa and Yoshimoto Sekine and Toshiya Inada and Norio Ozaki and Nakao Iwata and Mutsuo Harano and Tokutaro Komiyama and Mitsuhiko Yamada and Ichiro Sora and Hiroshi Ujike and Masaomi Iyo",
year = "2008",
month = "10",
day = "5",
doi = "10.1002/ajmg.b.30703",
language = "English",
volume = "147",
pages = "1040--1046",
journal = "American Journal of Medical Genetics, Part B: Neuropsychiatric Genetics",
issn = "1552-4841",
publisher = "Wiley-Liss Inc.",
number = "7",

}

Hashimoto, T, Hashimoto, K, Miyatake, R, Matsuzawa, D, Sekine, Y, Inada, T, Ozaki, N, Iwata, N, Harano, M, Komiyama, T, Yamada, M, Sora, I, Ujike, H & Iyo, M 2008, 'Association study between polymorphisms in glutathione-related genes and methamphetamine use disorder in a Japanese population', American Journal of Medical Genetics, Part B: Neuropsychiatric Genetics, vol. 147, no. 7, pp. 1040-1046. https://doi.org/10.1002/ajmg.b.30703

Association study between polymorphisms in glutathione-related genes and methamphetamine use disorder in a Japanese population. / Hashimoto, Tasuku; Hashimoto, Kenji; Miyatake, Ryosuke; Matsuzawa, Daisuke; Sekine, Yoshimoto; Inada, Toshiya; Ozaki, Norio; Iwata, Nakao; Harano, Mutsuo; Komiyama, Tokutaro; Yamada, Mitsuhiko; Sora, Ichiro; Ujike, Hiroshi; Iyo, Masaomi.

In: American Journal of Medical Genetics, Part B: Neuropsychiatric Genetics, Vol. 147, No. 7, 05.10.2008, p. 1040-1046.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Association study between polymorphisms in glutathione-related genes and methamphetamine use disorder in a Japanese population

AU - Hashimoto, Tasuku

AU - Hashimoto, Kenji

AU - Miyatake, Ryosuke

AU - Matsuzawa, Daisuke

AU - Sekine, Yoshimoto

AU - Inada, Toshiya

AU - Ozaki, Norio

AU - Iwata, Nakao

AU - Harano, Mutsuo

AU - Komiyama, Tokutaro

AU - Yamada, Mitsuhiko

AU - Sora, Ichiro

AU - Ujike, Hiroshi

AU - Iyo, Masaomi

PY - 2008/10/5

Y1 - 2008/10/5

N2 - Accumulating evidence suggests that oxidative stress plays a role in the mechanisms of action of methamphetamine (METH) in the brain. In the present study, we investigated the association between the genetic polymorphisms among glutathione (GSH)-related enzymes; glutathione S-transferases (GSTs) such as GSTT1 (Non-deletion/Null), GSTT2 (Met139Ile), GSTA1 (-69C/T), and GSTO1 (Ala140Asp); glutathione peroxidase 1 (GPX1) (Pro198Leu); and glutamate-cysteine ligase modifier (GCLM) subunit and METH use disorder in a Japanese population. Two hundred eighteen METH abusers and 233 healthy controls were enrolled in the study. There was a significant difference in GSTT1 genotype frequency between patients with METH psychosis and controls (P = 0.039, odds ratio: 1.52, 95% CI 1.03-2.24). Furthermore, the frequency (66.0%) of the GSTT1 null genotype among prolonged-type METH psychotic patients with spontaneous relapse was significantly higher (P = 0.025, odds ratio: 2.43, 95% CI 1.13-5.23) than that (44.4%) of transient-type METH psychotic patients without spontaneous relapse. However, there were no associations between the polymorphisms of other genes and METH abuse. The present study suggests that the polymorphism of the GSTT1 gene might be a genetic risk factor of the development of METH psychosis in a Japanese population.

AB - Accumulating evidence suggests that oxidative stress plays a role in the mechanisms of action of methamphetamine (METH) in the brain. In the present study, we investigated the association between the genetic polymorphisms among glutathione (GSH)-related enzymes; glutathione S-transferases (GSTs) such as GSTT1 (Non-deletion/Null), GSTT2 (Met139Ile), GSTA1 (-69C/T), and GSTO1 (Ala140Asp); glutathione peroxidase 1 (GPX1) (Pro198Leu); and glutamate-cysteine ligase modifier (GCLM) subunit and METH use disorder in a Japanese population. Two hundred eighteen METH abusers and 233 healthy controls were enrolled in the study. There was a significant difference in GSTT1 genotype frequency between patients with METH psychosis and controls (P = 0.039, odds ratio: 1.52, 95% CI 1.03-2.24). Furthermore, the frequency (66.0%) of the GSTT1 null genotype among prolonged-type METH psychotic patients with spontaneous relapse was significantly higher (P = 0.025, odds ratio: 2.43, 95% CI 1.13-5.23) than that (44.4%) of transient-type METH psychotic patients without spontaneous relapse. However, there were no associations between the polymorphisms of other genes and METH abuse. The present study suggests that the polymorphism of the GSTT1 gene might be a genetic risk factor of the development of METH psychosis in a Japanese population.

UR - http://www.scopus.com/inward/record.url?scp=55349089241&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=55349089241&partnerID=8YFLogxK

U2 - 10.1002/ajmg.b.30703

DO - 10.1002/ajmg.b.30703

M3 - Article

C2 - 18186040

AN - SCOPUS:55349089241

VL - 147

SP - 1040

EP - 1046

JO - American Journal of Medical Genetics, Part B: Neuropsychiatric Genetics

JF - American Journal of Medical Genetics, Part B: Neuropsychiatric Genetics

SN - 1552-4841

IS - 7

ER -